Key Takeaways in Renal Cell Carcinoma from Abstract 4512

The panel examines the key findings from abstract 4512 and evaluates its potential impact on the current treatment paradigm for renal cell carcinoma.

EP: 1.Overview of RCC Histology and Incidence Rates

EP: 2.CLEAR Trial Updates From ASCO 2024

EP: 3.TKIs, Disease Progression and Subsequent Therapy in RCC

EP: 4.ASCO 2024 Updates: nccRCC + Chromophobe RCC

EP: 5.PAPMET Phase II Trial Advances Cancer Treatment Landscape

EP: 6.Chromophobe Renal Cell Carcinoma: Key Features and Diagnosis

EP: 7.Examining Predictors of Chromophobe Renal Cell Carcinoma Recurrence

EP: 8.ASCO 2024: Abstract 4512 Overview

Now Viewing

EP: 9.Key Takeaways in Renal Cell Carcinoma from Abstract 4512

EP: 10.Phase II and KEYNOTE B-61: Comparative Analysis of Cancer Trials

Recent Videos